Answers are grounded in this paper and cite their sources.
This case study highlights the aggressive nature of CAPS, emphasizing treatment strategies and diagnostic importance in young individuals.
This case provides key learning points, underscoring the heterogeneity and aggressiveness of CAPS, the importance of systematic exclusion of mimics when histopathology is not feasible, and the value of early "triple therapy" with escalation (e.g., rituximab) in refractory presentations. Large-vessel with cardiac extension (SVC→RA) in CAPS is uncommon and warrants heightened suspicion, even in young patients without conventional risk factors.
No takes yet. Share an insight, caveat, or question.
Skafi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: